Feng Zuxi, Liao Minjing, Zhang Liansheng
The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, 730000, China.
Department of Hematology, Lanzhou University Second Hospital, Lanzhou, 730000, China.
J Transl Med. 2024 Dec 27;22(1):1150. doi: 10.1186/s12967-024-05990-2.
Sex is a fundamental biological variable that influences immune system function, with sex chromosomes (X and Y) playing a central role in these differences. Despite substantial evidence of disparities in immune responses between males and females, biomedical research has historically overlooked sex as a critical factor. This oversight has contributed to the observed disparities in susceptibility to autoimmune diseases, infectious diseases, and malignancies between the sexes. In this review, we address the phenomena and mechanisms through which aberrant expression of sex chromosome-linked genes contributes to sex-based differences in immune responses. We specifically focus on the implications of X chromosome inactivation (XCI) escape and loss of Y chromosome (LOY). Our review aims to elucidate the molecular mechanisms driving these sex-based differences, with particular emphasis on the interactions between sex chromosome genes and immune cells in both males and females. Additionally, we discuss the potential impact of these differences on disease susceptibility and identify prospective therapeutic targets. As personalized and precision medicine advances, it is crucial to integrate sex differences into immunological research and clinical trials. We advocate for an increased focus on sex-based considerations in fundamental, translational, and clinical research to promote personalized, sex-specific healthcare.
性别是影响免疫系统功能的一个基本生物学变量,性染色体(X和Y)在这些差异中起着核心作用。尽管有大量证据表明男性和女性的免疫反应存在差异,但生物医学研究在历史上一直忽视性别这一关键因素。这种忽视导致了两性在自身免疫性疾病、传染病和恶性肿瘤易感性方面存在明显差异。在这篇综述中,我们阐述了性染色体连锁基因的异常表达导致免疫反应性别差异的现象和机制。我们特别关注X染色体失活(XCI)逃逸和Y染色体丢失(LOY)的影响。我们的综述旨在阐明驱动这些性别差异的分子机制,特别强调男性和女性中性染色体基因与免疫细胞之间的相互作用。此外,我们讨论了这些差异对疾病易感性的潜在影响,并确定潜在的治疗靶点。随着个性化和精准医学的发展,将性别差异纳入免疫学研究和临床试验至关重要。我们主张在基础、转化和临床研究中更多地关注基于性别的因素,以促进个性化的、针对性别的医疗保健。